iShares Genomics Immunology and Healthcare ETF (IDNA)

Assets	$135.51M
Expense Ratio	0.47%
PE Ratio	2.23
Shares Out	5.85M
Dividend (ttm)	$0.28
Dividend Yield	1.23%
Ex-Dividend Date	Jun 11, 2024
Payout Ratio	2.74%
1-Year Return	-1.78%

Volume	48,876
Open	23.08
Previous Close	23.16
Day's Range	22.76 - 23.11
52-Week Low	17.33
52-Week High	25.22
Beta	1.17
Holdings	67
Inception Date	Jun 11, 2019

About IDNA

Fund Home Page

The iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering. IDNA was launched on Jun 11, 2019 and is issued by BlackRock.

• Asset Class: Equity
• Category: Health
• Stock Exchange: NYSEARCA
• Ticker Symbol: IDNA
• ETF Provider: BlackRock
• Index Tracked: NYSE FactSet Global Genomics and Immuno Biopharma Index

Top 10 Holdings

43.12% of assets

Name	Symbol	Weight
Sarepta Therapeutics, Inc.	SRPT	5.25%
Gilead Sciences, Inc.	GILD	4.41%
Regeneron Pharmaceuticals, Inc.	REGN	4.38%
Incyte Corporation	INCY	4.37%
Roche Holding AG	ROG.SW	4.29%
Exelixis, Inc.	EXEL	4.17%
Merck & Co., Inc.	MRK	4.17%
BeiGene Ltd Ordinary Shares	6160.HK	4.05%
Sanofi SA	SAN.PA	4.04%
GSK PLC	GSK.L	4.00%

Dividends

Ex-Dividend	Amount	Pay Date
Jun 11, 2024	$0.11144	Jun 17, 2024
Dec 20, 2023	$0.16925	Dec 27, 2023
Jun 7, 2023	$0.07077	Jun 13, 2023
Jun 9, 2022	$0.1359	Jun 15, 2022
Dec 13, 2021	$0.25636	Dec 17, 2021
Jun 10, 2021	$0.05215	Jun 16, 2021